In November 2023 the UKAR Steering Committee hosted its autumn industry engagement meeting where progress with site and patient recruitment was shared. This was closely followed by a poster sharing progress to date at the BSAC Winter Conference and an opportunity for delegates to discuss UKAR with the study team.
As of November 2023 there were 9 sites actively recruiting, 22 sites in set-up phase and 15 sites exploring feasibility to join. Data collection was underway for 52 patients receiving 5 of the 11 study drugs.
Recruitment of sites is on track and patient recruitment growing as expected. The team is looking forward to sharing initial results in 2024.